يعرض 1 - 10 نتائج من 140 نتيجة بحث عن '"D. V. Kuznetsov"', وقت الاستعلام: 1.08s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية

    المؤلفون: D. V. Kuznetsov

    المصدر: Вестник Кемеровского государственного университета, Vol 0, Iss 2-2, Pp 101-105 (2013)

    وصف الملف: electronic resource

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    المصدر: Creative surgery and oncology; Том 13, № 1 (2023); 87-92 ; Креативная хирургия и онкология; Том 13, № 1 (2023); 87-92 ; 2076-3093 ; 2307-0501

    وصف الملف: application/pdf

    العلاقة: https://www.surgonco.ru/jour/article/view/775/541Test; Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P. 3rd, Gentile F., et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2021;143:e35–71. DOI:10.1161/CIR.0000000000000932; Baumgartner H., Falk V., Bax J.J., De Bonis M., Hamm C., Holm P.J., et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91. DOI:10.1093/eurheartj/ehx391; Ozaki S., Kawase I., Yamashita H., Uchida S., Nozawa Y., Matsuyama T., et al. Aortic valve reconstruction using self-developed aortic valve plasty system in aortic valve disease. Interact Cardiovasc Thorac Surg. 2011;12:550–3. DOI:10.1510/icvts.2010.253682; Arutyunyan V., Chernov I., Komarov R., Sinelnikov Y., Kadyraliev B., Enginoev S., et al. Immediate outcomes of aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium: A multicenter study. Brazilian J Cardiovasc Surg. 2020;35:241–8. DOI:10.21470/1678-9741-2020-0019; Sa M.P., Chernov I., Marchenko A., Chagyan V., Komarov R., Askadinov M., et al. Aortic valve neocuspidization (Ozaki Procedure) in patients with small aortic annulus (≤21 mm): a multicenter study. Struct Hear. 2020;4(5):413–9. DOI:10.1080/24748706.2020.1792595; Sá M.P., Perazzo Á.M., Zhigalov K., Komarov R., Kadyraliev B., Enginoev S., et al. Aortic valve neocuspidization with glutaraldehydetreated autologous pericardium (Ozaki procedure) — a promising surgical technique. Brazilian J Cardiovasc Surg. 2019;34:610–4. DOI:10.21470/1678-9741-2019-0304; Чернов И.И., Энгиноев С.Т., Комаров Р.Н., Тарасов Д.Г., Синельников Ю.С., Марченко А.В. и др. Трехлетние результаты операции Озаки у пациентов 65 лет и старше: многоцентровое исследование. Патология кровообращения и кардиохирургия. 2021;25(4):53–63. DOI:10.21688/1681-3472-2021-4-53-63; Чернов И.И., Энгиноев С.Т., Комаров Р.Н., Базылев В.В., Тарасов Д.Г., Кадыралиев К.Б. и др. Непосредственные результаты операции Ozaki: многоцентровое исследование. Российский кардиологический журнал. 2020;25(S4):4157. DOI:10.15829/15604071-2020-4157; Pirola S., Mastroiacovo G., Arlati F.G., Mostardini G., Bonomi A., Penza E., et al. Single center five years’ experience of Ozaki procedure: midterm follow-up. Ann Thorac Surg. 2021;111(6):1937–43. DOI:10.1016/j.athoracsur.2020.08.039; Ozaki S., Kawase I., Yamashita H., Nozawa Y., Takatoh M., Hagiwara S., et al. Aortic valve reconstruction using autologous pericardium for patients aged less than 60 years. J Thorac Cardiovasc Surg. 2014;148:934–8. DOI:10.1016/j.jtcvs.2014.05.041; Mylonas K.S., Tasoudis P.T., Pavlopoulos D., Kanakis M., Stavridis G.T., Avgerinos D.V. Aortic valve neocuspidization using the Ozaki technique: A meta-analysis of reconstructed patient-level data. Am Heart J. 2023;255:1–11. DOI:10.1016/j.ahj.2022.09.003; Makino M., Yamamoto H., Ishibashi-Ueda H., Nakamura Y. A case of aortic valve leaflet tear and perforations after neocuspidization. ESC Hear Fail. 2019;6:446–8. DOI:10.1002/ehf2.12415; Tada N., Tanaka N., Abe K., Hata M. Transcatheter aortic valve implantation after aortic valve neocuspidization using autologous pericardium: a case report. Eur Hear J — Case Reports. 2019;3:ytz105. DOI:10.1093/ehjcr/ytz105; Amabile A., Krane M., Dufendach K., Baird C.W., Ganjoo N., Eckstein F.S., et al. Standardized aortic valve neocuspidization for treatment of aortic valve diseases. Ann Thorac Surg. 2022;114(4):1108–17. DOI:10.1016/j.athoracsur.2022.03.067; Ozaki S., Kawase I., Yamashita H., Uchida S., Takatoh M., Kiyohara N. Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2018;155:2379–87. DOI:10.1016/j.jtcvs.2018.01.087; Duran C.M., Gallo R., Kumar N. Aortic valve replacement with autologous pericardium: surgical technique. J Card Surg 1995;10:1–9. DOI:10.1111/j.1540-8191.1995.tb00582.x; Reuthebuch O., Koechlin L., Schurr U., Grapow M., Fassl J., Eckstein F.S. Aortic valve replacement using autologous pericardium: single centre experience with the Ozaki technique. Swiss Med Wkly. 2018;148:w14591. DOI:10.4414/smw.2018.14591; Habib G., Lancellotti P., Antunes M.J., Bongiorni M.G., Casalta J.-P., Del Zotti F., et al. 2015 ESC Guidelines for the management of infective endocarditis: The task force for the management of infective endocarditis of the European society of cardiology (ESC). Endorsed by: European association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J. 2015;36(44):3075–128. DOI:10.1093/eur-heartj/ehv319; Ma W.-G., Hou B., Abdurusul A., Gong D.-X., Tang Y., Chang Q., et al. Dysfunction of mechanical heart valve prosthesis: experience with surgical management in 48 patients. J Thorac Dis. 2015;7:2321–9. DOI:10.3978/j.issn.2072-1439.2015.12.25; Leontyev S., Borger M.A., Davierwala P., Walther T., Lehmann S., Kempfert J., et al. Redo aortic valve surgery: early and late outcomes. Ann Thorac Surg. 2011;91:1120–6. DOI:10.1016/j.athoracsur.2010.12.053; Khan J.M., Greenbaum A.B., Babaliaros V.C., Rogers T., Eng M.H., Paone G., et al. The BASILICA Trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv. 2019;12:1240–52. DOI:10.1016/j.jcin.2019.03.035; https://www.surgonco.ru/jour/article/view/775Test